Texas Retina Associates’ Robert C. Wang, MD, shared three case studies in an article titled “Long-term Inflammation Control Benefits All Types of Uveitis” published in the November/December 2020 issue of the medical journal Retina Today. Uveitis is a rare retinal disease where the body’s immune system attacks the eye, causing inflammation.

Highlights of the article include:

  • The goal of uveitis treatment is to achieve quiescence (inactivity or dormancy) with the fewest possible side effects.
  • A number of implantable posterior segment steroid options exist for local control of inflammation.
  • Ongoing coverage is a chief advantage of an implantable corticosteroid.

You can access the full article here.

In addition to providing medical retina care and vitreoretinal surgery, Dr. Wang sub-specializes in the diagnosis and treatment of uveitis. He sees patients in our Dallas Main, Dallas North, Plano and Sherman offices. Dr. Wang also serves as Director of Clinical Research for our Plano office. You can learn more about him here.